- Home
- CELC vs CPK Comparison
CELC vs CPK Comparison
Compare CELC & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CPK
- Stock Information
- Founded
- CELC 2011
- CPK 1990
- Country
- CELC United States
- CPK United States
- Employees
- CELC N/A
- CPK N/A
- Industry
- CELC Medical Specialities
- CPK Oil & Gas Production
- Sector
- CELC Health Care
- CPK Utilities
- Exchange
- CELC Nasdaq
- CPK Nasdaq
- Market Cap
- CELC 3.1B
- CPK 2.9B
- IPO Year
- CELC 2017
- CPK N/A
- Fundamental
- Price
- CELC $100.23
- CPK $139.53
- Analyst Decision
- CELC Strong Buy
- CPK Hold
- Analyst Count
- CELC 7
- CPK 2
- Target Price
- CELC $95.29
- CPK $135.00
- AVG Volume (30 Days)
- CELC 916.2K
- CPK 151.2K
- Earning Date
- CELC 11-12-2025
- CPK 11-06-2025
- Dividend Yield
- CELC N/A
- CPK 1.98%
- EPS Growth
- CELC N/A
- CPK 14.49
- EPS
- CELC N/A
- CPK 5.62
- Revenue
- CELC N/A
- CPK $886,100,000.00
- Revenue This Year
- CELC N/A
- CPK $12.34
- Revenue Next Year
- CELC N/A
- CPK $5.79
- P/E Ratio
- CELC N/A
- CPK $24.62
- Revenue Growth
- CELC N/A
- CPK 16.97
- 52 Week Low
- CELC $7.58
- CPK $115.12
- 52 Week High
- CELC $103.06
- CPK $140.59
- Technical
- Relative Strength Index (RSI)
- CELC 78.25
- CPK 66.02
- Support Level
- CELC $92.10
- CPK $134.85
- Resistance Level
- CELC $103.06
- CPK $138.62
- Average True Range (ATR)
- CELC 5.52
- CPK 2.97
- MACD
- CELC 0.74
- CPK 0.45
- Stochastic Oscillator
- CELC 90.84
- CPK 97.11
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CPK Chesapeake Utilities Corporation
Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.